ConductScience.org, home

Paper34827367

Effect of Imipenem and Amikacin Combination against Multi-Drug Resistant Pseudomonas aeruginosa.

Farhan SM and 6 others. Antibiotics (Basel), 2021. Cited by 19 papers, by iCite.

Cite this record

ConductScience Library. Effect of Imipenem and Amikacin Combination against Multi-Drug Resistant Pseudomonas aeruginosa. Papers, record 34827367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34827367

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of Imipenem and Amikacin Combination against Multi-Drug Resistant Pseudomonas aeruginosa.
PubMed
Journal
Antibiotics (Basel)
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
1.71
iCite
Revised in PubMed
2021-11-30
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Farhan SMSara Mahmoud
2Raafat MMohamedhttps://orcid.org/0000-0002-1052-2940
3Abourehab MASMohammed A Shttps://orcid.org/0000-0003-1348-6567
4Abd El-Baky RMRehab Mahmoudhttps://orcid.org/0000-0001-6094-5653
5Abdalla SSalah
6El-Gendy AOAhmed Osamahttps://orcid.org/0000-0002-0980-5185
7Azmy AFAhmed Farag

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131921603In vitro antibacterial activity of curcumin-meropenem combination against extensively drug-resistant (XDR) bacteria isolated from burn wound infections.Avicenna J Phytomed2020https://conductscience.org/library/papers/31921603PubMed
210747827Imipenem, doxycycline and amikacin in monotherapy and in combination in Acinetobacter baumannii experimental pneumonia.J Antimicrob Chemother2000https://conductscience.org/library/papers/10747827PubMed
317300908The effect of amikacin and imipenem alone and in combination against an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain.Diagn Microbiol Infect Dis2007https://conductscience.org/library/papers/17300908PubMed
428306360The antibiotic pipeline: reviving research and development and speeding drugs to market.Expert Rev Anti Infect Ther2017https://conductscience.org/library/papers/28306360PubMed
530389638Aminoglycoside-modifying enzyme and 16S ribosomal RNA methyltransferase genes among a global collection of Gram-negative isolates.J Glob Antimicrob Resist2019https://conductscience.org/library/papers/30389638PubMed
622779068Characterization of carbapenemase genes in Enterobacteriaceae species exhibiting decreased susceptibility to carbapenems in a university hospital in Chongqing, China.Ann Lab Med2012https://conductscience.org/library/papers/22779068PubMed
721514795In vitro activities of ceftobiprole combined with amikacin or levofloxacin against Pseudomonas aeruginosa: evidence of a synergistic effect using time-kill methodology.Int J Antimicrob Agents2011https://conductscience.org/library/papers/21514795PubMed
830959050β-Lactamases and β-Lactamase Inhibitors in the 21st Century.J Mol Biol2019https://conductscience.org/library/papers/30959050PubMed
93312985Mechanism of bactericidal action of aminoglycosides.Microbiol Rev1987https://conductscience.org/library/papers/3312985PubMed
1027133391Colistin-sparing regimens against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates: Combination of tigecycline or doxycycline and gentamicin or amikacin.J Microbiol Immunol Infect2019https://conductscience.org/library/papers/27133391PubMed
1121173183Efflux-mediated antibiotic resistance in Acinetobacter spp.Antimicrob Agents Chemother2011https://conductscience.org/library/papers/21173183PubMed
1211810504Activities of beta-lactams, fluoroquinolones, amikacin and fosfomycin alone and in combination against Pseudomonas aeruginosa isolated from complicated urinary tract infections.J Infect Chemother1999https://conductscience.org/library/papers/11810504PubMed
131816177Mechanisms of resistance to beta-lactam antibiotics in Acinetobacter calcoaceticus.J Antimicrob Chemother1991https://conductscience.org/library/papers/1816177PubMed
1419223616Intracellular activity of antibiotics against Staphylococcus aureus in a mouse peritonitis model.Antimicrob Agents Chemother2009https://conductscience.org/library/papers/19223616PubMed
1519822890Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.Clin Microbiol Rev2009https://conductscience.org/library/papers/19822890PubMed
1631924522In vitro effect of an antimicrobial combination therapy without colistin and tigecycline for CPE and non-CPE.J Infect Chemother2020https://conductscience.org/library/papers/31924522PubMed
1715131172PCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patients.J Clin Microbiol2004https://conductscience.org/library/papers/15131172PubMed
1816504059Statistical analysis of real-time PCR data.BMC Bioinformatics2006https://conductscience.org/library/papers/16504059PubMed
1929420743Meropenem potentiation of aminoglycoside activity against Pseudomonas aeruginosa: involvement of the MexXY-OprM multidrug efflux system.J Antimicrob Chemother2018https://conductscience.org/library/papers/29420743PubMed
2031406468Antimicrobial resistance pattern and molecular genetic distribution of metallo-β-lactamases producing Pseudomonas aeruginosa isolated from hospitals in Minia, Egypt.Infect Drug Resist2019https://conductscience.org/library/papers/31406468PubMed

See all 35 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
42837086
Surface charge-dependent effects of BSA-curcumin nanoparticles combined with amikacin in antimicrobial photodynamic therapy: A pilot In Vivo study of multidrug-resistant Pseudomonas aeruginosa skin infection.
Lasers Med Sci2026https://conductscience.org/library/papers/42837086PubMed
42197354Synergistic Inhibition of Acinetobacter baumannii Biofilm Formation and Reduction of Lung Inflammation In Vivo by Combination of α-Pinene and Meropenem.Microorganisms2026https://conductscience.org/library/papers/42197354PubMed
42194908Study of the Impact of Antibiotic Combinations Used in Urinary Tract Infections on the Effectiveness of Antimicrobial Therapy.J Clin Med2026https://conductscience.org/library/papers/42194908PubMed
41925990In Vitro Antibacterial Effect of Probiotics Against Bacterial Isolates from Diabetic Foot Ulcers in Ain Shams University Hospitals.Probiotics Antimicrob Proteins2026https://conductscience.org/library/papers/41925990PubMed
41720900Synergistic effects of meropenem, amikacin, and ciprofloxacin against carbapenem resistant Pseudomonas aeruginosa isolates.Sci Rep2026https://conductscience.org/library/papers/41720900PubMed
41463779Occurrence of Virulence and Antibiotic Resistance in Pseudomonas aeruginosa Isolated from the Environmental Water from Tamaulipas, Mexico.Antibiotics (Basel)2025https://conductscience.org/library/papers/41463779PubMed
40572777A Retrospective Study on the Prevalence and Antimicrobial Susceptibility of Gram-Positive Cocci in a Pediatric Department: A Single-Center Report from Egypt.Medicina (Kaunas)2025https://conductscience.org/library/papers/40572777PubMed
40428842
The Efficacy and Tolerability of Colistin Versus Non-Colistin Antimicrobial Regimens Among Hospitalized COVID-19 Patients with Multidrug-Resistant Bacterial Superinfection: An Observational Multicenter Study.
Medicina (Kaunas)2025https://conductscience.org/library/papers/40428842PubMed
40131859RETRACTED: The effect of biosynthesized silver nanoparticles on Pseudomonas aeruginosa-infected dogs wounds.PLoS One2025https://conductscience.org/library/papers/40131859PubMed
39354545Investigation of in vitro susceptibility and resistance mechanisms to amikacin among diverse carbapenemase-producing Enterobacteriaceae.BMC Med Genomics2024https://conductscience.org/library/papers/39354545PubMed
38116135Metabolomics reveals the mechanism of action of meropenem and amikacin combined in the treatment of Pseudomonas aeruginosa.Front Cell Infect Microbiol2023https://conductscience.org/library/papers/38116135PubMed
37895978Comparative Investigation into the Roles of Imipenem:Cyclodextrin Complexation and Antibiotic Combination in Combatting Antimicrobial Resistance in Gram-Negative Bacteria.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/37895978PubMed
36830309Evidence-Based Treatment of Pseudomonas aeruginosa Infections: A Critical Reappraisal.Antibiotics (Basel)2023https://conductscience.org/library/papers/36830309PubMed
36318447The comparative effects of erythromycin and amikacin on acute respiratory Pseudomonas aeruginosa infection.Vet Med Sci2023https://conductscience.org/library/papers/36318447PubMed
36281514Emergence of NDM-1-producing Pseudomonas aeruginosa Sequence Type 773 Clone: Shift of Carbapenemase Molecular Epidemiology and Spread of 16S rRNA Methylase Genes in Korea.Ann Lab Med2023https://conductscience.org/library/papers/36281514PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34827367

GET https://conductscience.org/api/papers/v1/34827367/references?page=2